Diagnostics & Research

Week ending 29 May 2026 · Index 120.51 · Weekly return 2.98%. Constituents are ranked by weekly return.

Sector Healthcare

Universe all active equity exchanges for the country

Price basis Adjusted weekly close

Index chart

Index Value Trend Line Fair Value Activity Lines

For the week ending 29 May 2026, Diagnostics & Research advanced 2.98% with 5 advancing, 4 declining, and 1 unchanged constituents.

Ticker Company Exchange Open High Low Close Return

CLBX CelLBxHealth plc LSE 1.75 2.80 1.50 2.15 22.86%

GDR genedrive plc LSE 1.15 1.35 1.15 1.30 13.04%

ABDX Abingdon Health Plc LSE 11.50 12.50 11.00 12.00 4.35%

IDHC Integrated Diagnostics Holdings plc LSE 0.56 0.60 0.53 0.60 2.93%

HVO hVIVO plc LSE 8.10 8.32 7.90 8.30 2.47%

VRCI Verici Dx plc LSE 0.43 0.45 0.40 0.43 0.00%

GENI GENinCode Plc LSE 1.08 1.10 1.00 1.05 -2.33%

OBD Oxford BioDynamics Plc LSE 0.19 0.20 0.16 0.19 -2.63%

EDX EDX Medical Group Plc LSE 11.75 12.50 10.50 11.25 -4.26%

PRM Proteome Sciences plc LSE 1.60 2.17 1.40 1.40 -6.67%